As fears grow that a full-blown COVID-19 pandemic may be on the way, a European public-private consortium is to offer a total of €45m (US$49m) in funding for projects aimed at accelerating the development of therapeutics and diagnostics to tackle the current outbreak and any future coronavirus threats.
The Innovative Medicines Initiative, a joint enterprise between the European Commission and the European industry federation, EFPIA, is planning to launch a fast-track call for proposals on combatting coronavirus infections (particularly COVID-19)
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?